Oncology and haematology in 2013. Some advances, but too many new treatments with an inadequately assessed harm-benefit balance
Prescrire International 23(148): 103-105
2014
ISSN/ISBN: 1167-7422 PMID: 24860901 Document Number: 671710
Document emailed within 1 workday
Related Documents
2013: Ivacaftor. Uncertain harm-benefit balance Prescrire international 22(142): 229-231Davies, M.; Daly, P.; Walsh, A. 1987: Death in a haematology/oncology unit: an analysis of 251 cases Irish Medical Journal 80(4): 117-119
Prasansuk, S.; Siriyananda, C.; Nakorn, A.Na.; Atipas, S.; Chongvisal, S. 2004: Balance disorders in the elderly and the benefit of balance exercise Journal of the Medical Association of Thailand 87(10): 1225-1233
Stiefelhagen, P. 2005: Plant drugs in kidney diseases. more harm than benefit? MMW Fortschritte der Medizin 147(8): 10
Weber, R.; Knaup, P.; Knietitg, R.; Haux, R.; Merzweiler, A.; Mludek, V.; Schilling, F.H.; Wiedemann, T. 2001: Object-oriented business process analysis of the cooperative soft tissue sarcoma trial of the german society for paediatric oncology and haematology (GPOH) Studies in Health Technology and Informatics 84(Pt 1): 58-62
Einecke, D. 2006: Stable coronary disease patients: more harm than benefit from heart catheter? MMW Fortschritte der Medizin 148(38): 12-14
Musa, J. 2011: Withholding breast milk for HIV exposed infants in sub-Saharan Africa: benefit or harm? African Health Sciences 11(4): 602-604
2009: Complex regional pain syndrome type 1. Some treatments assessed versus placebo, limited efficacy Prescrire international 18(104): 267-271
Ashford, N.A. 1982: Cost-benefit analysis: can balance be achieved? Occupational Health and Safety 51(5): 10-12; 42-45
Edelman, A. 2015: Teens and young adults should be started on long-acting reversible contraceptives before sexual activity commences: AGAINST: Pre-emptive use without need or benefit may cause more harm than good Bjog: An International Journal of Obstetrics and Gynaecology 122(8): 1052
Edelman, A. 2015: Teens and young adults should be started on long-acting reversible contraceptives before sexual activity commences: AGAINST: Pre-emptive use without need or benefit may cause more harm than good Bjog: An International Journal of Obstetrics and Gynaecology 122(8): 1052
Tanabe, T.; Iwamoto, T.; Fusegawa, Y.; Yoshioka, K.; Shiina, Y. 1995: Alterations of sympathovagal balance in patients with hypertrophic and dilated cardiomyopathies assessed by spectral analysis of RR interval variability European Heart Journal 16(6): 799-807
von Schweinitz, D.; Byrd, D.J.; Hecker, H.; Weinel, P.; Bode, U.; Bürger, D.; Erttmann, R.; Harms, D.; Mildenberger, H. 1997: Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology European Journal of Cancer 33(8): 1243-1249
Matthias, J.Q. 1973: Advances in oncology Practitioner 211(264): 465-475
Russel, A.J. 1995: The use of navoban in the therapy of oncology patients with highly emetic treatments Voprosy Onkologii 41(1): 87-90
Amin, R.; Ratnavel, R. 2003: Recent advances in topical treatments Practitioner 247(1643): 118-20 122 124 Passim
Scheen, A.J.; Paquot, N. 2013: Use of metformin in diabetic patients with cardiac disease: benefit-risk balance Revue Medicale Suisse 9(395): 1527-1533
Tieman, J. 2003: Senior citizens score win as drug benefit advances Modern Healthcare 33(24): 8-9
Swart, G.W. 2001: Advances in oncology--drug discovery and apoptosis Idrugs: the Investigational Drugs Journal 4(12): 1337-1338
Bins, S.; Schellens, J.H.M.; Voest, E.E.; Sleijfer, S. 2014: Drug research in oncology; advances in the genome era Nederlands Tijdschrift Voor Geneeskunde 158: A6801